Investor Relations

 

Transcat (Nasdaq:TRNS) has been a leader in the test and measurement industry for over 40 years. We strive to differentiate ourselves and build barriers to competitive entry by offering the best products, delivering high quality calibration and repair services, and integrating those products and services. We work diligently to create lasting value for our shareholders.

Strategy

Our strategy is to continue to grow our business through a blend of organic revenue growth and acquisitions. We leverage the complementary nature of our operating segments in ways that add value for all customers who select Transcat as their source for test and measurement equipment and/or calibration and laboratory instrument services. We believe our combined Service and Distribution segment offerings, experience, technical expertise and quality-oriented, integrity-based approach create a unique and compelling value proposition for our customers. We strive to differentiate ourselves within the markets we serve and build barriers to competitive entry by offering a broad range of the best products and services, and integrating those products and services to benefit our customers’ operations.

Annual Reports

Get access to Transcat’s annual reports, read meeting transcripts and view annual report presentations

Earnings Releases

View Transcat’s earnings releases, listen to presentation webcasts or view the presentation slides

Corporate Governance

View Transcat's corporate governance guidelines, board of directors, executive officers and senior management

Recent Company News

Transcat, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

ROCHESTER, NY, Sept 7, 2021 – Transcat, Inc. (NASDAQ: TRNS), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that Lee D. Rudow, Chief Executive Officer, and Mark A. Doheny, Chief Financial Officer, will present at the H.C. Wainwright 23rd Annual Global Investment Conference, taking place virtually September 13-15, 2021.

Transcat Expands Life Science Service Capabilities and Geographic Reach into Ireland with Acquisition of NEXA Enterprise Asset Management

ROCHESTER, NY, August 31, 2021 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it has purchased all of the capital stock of privately-held Cal Opex Limited (d/b/a NEXA Enterprise Asset Management), effective August 31, 2021. The purchase price of $22.5 million consisted of $20.25 million in cash and $2.25 million in Transcat common stock. Additionally, there are potential earn-out payments of up to $7.5 million over the next four years based upon NEXA achieving certain annual revenue and EBITDA goals. If achieved, the earn-out payments will also be made in common stock.

Transcat, Inc. to Present at Oppenheimer Technology, Internet, and Communications Virtual Conference

ROCHESTER, NY, August 5, 2021 – Transcat, Inc. (NASDAQ: TRNS), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that Lee D. Rudow, Chief Executive Officer, and Mark A. Doheny, Chief Financial Officer, will present and be available for investor meetings at the Oppenheimer Technology, Internet and Communications Virtual Conference on Wednesday, August 11, 2021.

 

For further information, please contact:

Mark A. Doheny
CFO
35 Vantage Point Drive
Rochester, NY 14624
Phone: 585.484.1350
Email: mark.doheny@transcat.com